Organization Overview
Historical Acquisition Tree
Alternative names
Key: Bristol-Myers Squibb (41) Acquired (28)
abatacept (orencia) (2005 NDA)
acetaminophen (tylenol) (1977)
acetylsalicylic acid (aspirin) (2003)
amitriptyline (elavil) (1978)
amphotericin b (fungizone) (1971)
apixaban (eliquis) (2012 NDA)
atazanavir (reyataz) (2003 NDA)
aztreonam (azactam) (1986)
belatacept (nujolix) (2011 NDA)
bleomycin (blenoxane) (1973)
buspirone (buspar) (1986)
butorphanol (stadol) (1991)
calcium chloride (1985)
carboplatin (paraplatin) (1989 NDA)
cefepime (maxipeme) (1996 NDA)
cefprozil (cefzil) (1991 NDA)
cholestyramine (questran) (1973)
cobicistat (stribild) (2015)
cyanocobalamin (berocca) (1950)
daclatasvir (daklinza) (2015 NDA)
dapagliflozin (farxiga) (2014 NDA)
dasatinib (sprycel) (2006 NDA)
didanosine (videx) (1991 NDA)
doxorubicin (Doxil) (1989)
efavirenz (sustiva) (1998)
elotuzumab (empliciti) (2015 NDA)
entecavir (baraclude) (2005 NDA)
estradiol (progynon depot) (1975)
etoposide (vepesid) (1998)
fluphenazine (permitil) (1972)
fosinopril (monopril) (NDA)
glipizide (glucotrol) (2002)
glucose monohydrate (1985)
glutathione (1985)
glyburide (micronase) (2000)
halobetasol (ultravate) (1990 NDA)
hydrochlorothiazide (esidrix) (1994)
hydroxyurea (hydrea) (1967)
ibuprofen (motrin) (1988)
Insulin, bovine (1950)
ipilimumab (yervoy) (2011 NDA)
ixabepilone (ixempra) (2007 NDA)
magnesium chloride (1985)
megestrol (megace) (1971)
metformin (glucophage) (1995 NDA)
mitomycin (mutamycin) (1981)
naloxone (narcan) (1988)
naltrexone (revia) (1989)
nefazodone (serzone) (1994 NDA)
nivolumab (opdivo) (2014 NDA)
oxycodone (oxycontin) (1977)
paclitaxel (taxol) (1992 NDA)
potassium chloride (klor-con) (1989)
pravastatin (pravachol) (1991 NDA)
procaine benzylpenicillin (novocaine) (1971)
protamine insulin (1950 NDA)
recombinant human choriogonadotropin alfa (Ovidrel) (1976)
sodium bicarbonate (1985)
sodium chloride (1985)
sodium phosphate (1985)
stavudine (zerit) (1994 NDA)
tc-99m gluceptate (glucoscan) (1978)
teniposide (vumon) (1992 NDA)
testolactone (teslac) (1969)
tioconazole (tz-3) (1997)
triflupromazine (vesprin) (1957)
tubocurarine (curare) (1945)
vincristine (oncovin) (1988)
warfarin (coumadin) (1954)
Key: Bristol-Myers Squibb (43) Acquired (69)
abatacept (orencia) (110 trials)
acamprosate (campral) (1 trial)
acetaminophen (tylenol) (7 trials)
acetylsalicylic acid (aspirin) (29 trials)
adalimumab (humira) (6 trials)
adefovir dipivoxil (hepsera) (9 trials)
alteplase (Activase) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (9 trials)
apixaban (eliquis) (77 trials)
apremilast (otezla) (80 trials)
aripiprazole (abilify) (74 trials)
atazanavir (reyataz) (66 trials)
azacitidine (vidaza) (109 trials)
belatacept (nujolix) (38 trials)
canakinumab (ilaris) (1 trial)
carboplatin (paraplatin) (118 trials)
celecoxib (celebrex) (4 trials)
certolizumab pegol (cimzia) (1 trial)
clavulanate (Augmentin) (2 trials)
clopidogrel (plavix) (37 trials)
collagenase clostridium histolyticum (xiaflex) (47 trials)
daclatasvir (daklinza) (71 trials)
diclofenac (voltaren) (2 trials)
efavirenz (sustiva) (33 trials)
emtricitabine (emtriva) (16 trials)
entecavir (baraclude) (34 trials)
etanercept (enbrel) (2 trials)
everolimus (zortress) (6 trials)
exenatide (byetta) (40 trials)
famotidine (pepcid) (16 trials)
frovatriptan (frova) (6 trials)
gabapentin (neurontin) (1 trial)
glimepiride (amaryl) (5 trials)
glipizide (glucotrol) (2 trials)
glyburide (micronase) (3 trials)
haloperidol (haldol) (2 trials)
heparin (liquaemin) (3 trials)
hydrochlorothiazide (esidrix) (5 trials)
hydromorphone (diladid) (1 trial)
immune globulin (human) (1 trial)
infliximab (remicade) (3 trials)
insulin glargine (toujeo) (6 trials)
insulin glulisine (Apidra) (1 trial)
insulin human (humulin) (4 trials)
insulin lispro (humalog) (2 trials)
irbesartan (avapro) (25 trials)
Lactobacillus acidophilus (5 trials)
lamivudine (epivir) (32 trials)
lamotrigine (lamictal) (1 trial)
lidocaine (xylocaine) (15 trials)
lithium (lithonate) (2 trials)
methylprednisolone (medrol) (14 trials)
mycophenolate (myfortic) (17 trials)
naltrexone (revia) (20 trials)
nefazodone (serzone) (1 trial)
nelfinavir (viracept) (9 trials)
nivolumab (opdivo) (579 trials)
olanzapine (zyprexa) (6 trials)
omeprazole (prilosec) (14 trials)
oxycodone (oxycontin) (3 trials)
oxymorphone (opana) (18 trials)
paclitaxel (taxol) (239 trials)
pramlintide (symlin) (23 trials)
prasugrel (effient) (3 trials)
pravastatin (pravachol) (7 trials)
procaine benzylpenicillin (novocaine) (2 trials)
propoxyphene (Darvon) (1 trial)
risperidone (risperdal) (7 trials)
ritonavir (Norvir) (51 trials)
saxagliptin (onglyza) (43 trials)
secukinumab (cosentyx) (1 trial)
sitagliptin (januvia) (65 trials)
tacrolimus (prograf) (18 trials)
technetium tc-99m sestamibi (1 trial)
telbivudine (tyzeka) (1 trial)
tenofovir (viread) (26 trials)
testosterone (delatestryl) (9 trials)
tetracaine (pontocaine) (1 trial)
thalidomide (Thalomid) (48 trials)
thrombin (human coagulation factor iia) (Recombinant) (Recothrom) (5 trials)
tinzaparin (Innohep) (4 trials)
tocilizumab (actemra) (4 trials)
tofacitinib (xeljanz) (1 trial)
topiramate (topamax) (1 trial)
unfractionated heparin (1 trial)
upadacitinib (Rinvoq) (1 trial)
valproic acid (depakene) (6 trials)
Key: Bristol-Myers Squibb (64) Acquired (115)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (3 trials)
acetylcysteine (mucomyst) (2 trials)
allogeneic stem cells (2 trials)
apomorphine (apokyn) (1 trial)
atenolol (tenormin) (2 trials)
autologous mononuclear stem cell (9 trials)
azathioprine (imuran) (1 trial)
bacampicillin (spectrobid) (1 trial)
bacille calmette-guerin (4 trials)
bendamustine (treanda) (20 trials)
bevacizumab (avastin) (34 trials)
bifidobacterium lactis (5 trials)
bleomycin (blenoxane) (4 trials)
bortezomib (velcade) (39 trials)
brentuximab vedotin (adcetris) (6 trials)
brivanib alaninate (18 trials)
cabozantinib (cometriq) (13 trials)
capecitabine (xeloda) (32 trials)
carbenicillin (pyopen) (1 trial)
carfilzomib (kyprolis) (21 trials)
cariprazine (vraylar) (2 trials)
cetuximab (erbitux) (93 trials)
chlorambucil (Leukeran) (1 trial)
ciprofloxacin (cipro) (3 trials)
cisplatin (platinol) (79 trials)
citalopram (celexa) (2 trials)
clarithromycin (biaxin) (11 trials)
cytarabine (cytosar-u) (18 trials)
dabigatran (pradaxa) (6 trials)
dacarbazine (dtic-dome) (14 trials)
dapagliflozin (farxiga) (60 trials)
daratumumab (darzalex) (19 trials)
darbepoetin alfa (aranesp) (2 trials)
darunavir (prezista) (4 trials)
didanosine (videx) (49 trials)
docetaxel (taxotere) (36 trials)
doxorubicin (Doxil) (47 trials)
duloxetine (Cymbalta) (4 trials)
durvalumab (imfinzi) (24 trials)
elotuzumab (empliciti) (40 trials)
enasidenib (idhifa) (19 trials)
endostatin (endostar) (1 trial)
enoxaparin (lovenox) (10 trials)
epirubicin (ellence) (11 trials)
erwinia asparaginase (Erwinaze) (1 trial)
escitalopram (lexapro) (7 trials)
estradiol (progynon depot) (1 trial)
etoposide (vepesid) (25 trials)
fedratinib (Inrebic) (11 trials)
fluorouracil (efudex) (49 trials)
galactooligosaccharide (1 trial)
gemcitabine (gemzar) (91 trials)
goserelin (zoladex) (2 trials)
histrelin (supprelin) (3 trials)
hyaluronidase (human recombinant) (hylenex) (5 trials)
hydrocortisone (solu-cortef) (1 trial)
inactivated influenza vaccine (2 trials)
irinotecan (Camptosar) (30 trials)
Isatuximab (Sarclisa) (2 trials)
ixabepilone (ixempra) (46 trials)
ixazomib (ninlaro) (12 trials)
ketoprofen (orudis) (5 trials)
lactobacillus delbrueckii (4 trials)
lenalidomide (revlimid) (354 trials)
lenvatinib (lenvima) (2 trials)
liraglutide (victoza) (1 trial)
lopinavir (Kaletra) (10 trials)
lubiprostone (amitiza) (1 trial)
luspatercept (Reblozyl) (11 trials)
melphalan (alkeran) (23 trials)
mepolizumab (Nucala) (1 trial)
mezlocillin (mezlin) (1 trial)
nevirapine (viramune) (6 trials)
octreotide (sandostatin) (4 trials)
ondansetron (zofran) (6 trials)
oxaliplatin (eloxatin) (40 trials)
peginterferon beta-1a (Plegridy) (1 trial)
peginterferon lambda-1a (14 trials)
pemetrexed (alimta) (27 trials)
phenprocoumon (liquamar) (2 trials)
pimecrolimus (elidel) (1 trial)
pioglitazone (actos) (11 trials)
pomalidomide (pomalyst) (81 trials)
prednisone (meticorten) (51 trials)
regorafenib (stivarga) (7 trials)
ribavirin (virazole) (48 trials)
rituximab (rituxan) (82 trials)
rivaroxaban (xarelto) (6 trials)
romidepsin (istodax) (35 trials)
rucaparib (rubraca) (6 trials)
saquinavir (invirase) (3 trials)
sargramostim (leukine) (17 trials)
sertraline (zoloft) (3 trials)
sofosbuvir (sovaldi) (12 trials)
sorafenib (nexavar) (13 trials)
sumatriptan (zecuity) (9 trials)
sunitinib (sutent) (10 trials)
telaprevir (incivek) (5 trials)
temozolomide (temodar) (18 trials)
thrombin (bovine) (Thrombostat) (1 trial)
tivozanib (Fotivda) (2 trials)
topotecan (hycamtin) (5 trials)
trazodone (desyrel) (5 trials)
trifluridine (viroptic) (1 trial)
valrubicin (valstar) (3 trials)
venlafaxine (effexor) (3 trials)
vinblastine (velban) (5 trials)
vincristine (oncovin) (20 trials)
vinorelbine (navelbine) (8 trials)
Key: Bristol-Myers Squibb (188) Acquired (166)
abemaciclib (verzenio) (3 trials)
abiraterone (zytiga) (4 trials)
aldesleukin (proleukin) (9 trials)
alemtuzumab (campath) (2 trials)
alendronic acid (fosamax) (1 trial)
allogeneic lymphocytes (3 trials)
allogeneic myeloma vaccine (1 trial)
allogeneic natural killer cells (3 trials)
allopurinol (zyloprim) (1 trial)
amino acids (Freamine) (1 trial)
amphotericin b (fungizone) (3 trials)
amprenavir (agenerase) (1 trial)
anastrozole (arimidex) (1 trial)
antigen-loaded cultured dendritic cells (1 trial)
apalutamide (erleada) (1 trial)
atezolizumab (tecentriq) (1 trial)
atorvastatin (lipitor) (2 trials)
autologous natural killer cells (1 trial)
autologous tumor infiltrating lymphocytes (4 trials)
basiliximab (simulect) (1 trial)
belinostat (beleodaq) (2 trials)
betamethasone (celestone) (1 trial)
bexarotene (targretin) (1 trial)
bezlotoxumab (zinplava) (1 trial)
bicalutamide (casodex) (2 trials)
bifidobacterium animalis (12 trials)
binimetinib (mektovi) (3 trials)
boceprevir (victrelis) (1 trial)
bosutinib (bosulif) (2 trials)
budesonide (rhinocort) (1 trial)
cabazitaxel (jevtana kit) (2 trials)
chlorotrianisene (tace) (1 trial)
cobimetinib (cotellic) (6 trials)
copanlisib (aliqopa) (1 trial)
crizotinib (xalkori) (4 trials)
dabrafenib (tafinlar) (3 trials)
daclizumab (Zenapax) (1 trial)
dactinomycin (cosmegen) (1 trial)
dalteparin (fragmin) (1 trial)
darolutamide (Nubeqa) (2 trials)
daunorubicin (cerubidine) (3 trials)
dc/aml fusion vaccine (1 trial)
decitabine (dacogen) (2 trials)
degarelix acetate (firmagon) (3 trials)
delavirdine (rescriptor) (1 trial)
dexmethylphenidate (focalin) (1 trial)
diphenhydramine (benadryl) (3 trials)
dolutegravir (tivicay) (1 trial)
eltrombopag (promacta) (1 trial)
encorafenib (braftovi) (2 trials)
entrectinib (Rozlytrek) (2 trials)
enzalutamide (xtandi) (2 trials)
erdafitinib (Balversa) (1 trial)
erlotinib (tarceva) (13 trials)
estramustine (emcyt) (2 trials)
exemestane (aromasin) (1 trial)
filgrastim (neupogen) (7 trials)
finasteride (Proscar) (1 trial)
fludarabine (fludara) (22 trials)
fludrocortisone (florinef) (1 trial)
fosamprenavir (lexiva) (1 trial)
gemtuzumab ozogamicin (mylotarg) (1 trial)
gvax pancreatic cancer vaccine (3 trials)
human placenta-derived cells (4 trials)
human placental derived stem cells (1 trial)
hydroxychloroquine (plaquenil) (2 trials)
hydroxyurea (hydrea) (5 trials)
ibrutinib (imbruvica) (16 trials)
idarubicin (idamycin) (3 trials)
idelalisib (zydelig) (3 trials)
incomplete freund's adjuvant (2 trials)
indomethacin (indocin) (1 trial)
interferon gamma-1b (actimmune) (1 trial)
ivosidenib (tibsovo) (1 trial)
lactobacillus rhamnosus (2 trials)
leuprolide (lupron) (4 trials)
levoleucovorin (fusilev) (1 trial)
linaclotide (linzess) (3 trials)
lisocabtagene maraleucel (3 trials)
live attenuated varicella vaccine (1 trial)
metformin (glucophage) (5 trials)
metreleptin (myalept) (6 trials)
midostaurin (rydapt) (1 trial)
miltefosine (impavido) (1 trial)
mitoxantrone (novantrone) (3 trials)
mogamulizumab (poteligeo) (1 trial)
necitumumab (portrazza) (1 trial)
nilotinib (tasigna) (2 trials)
nilutamide (nilandron) (1 trial)
nitroglycerin (transderm-nitro) (1 trial)
obinutuzumab (gazyva) (10 trials)
ofatumumab (arzerra) (5 trials)
osimertinib (tagrisso) (2 trials)
palbociclib (ibrance) (5 trials)
palifermin (kepivance) (1 trial)
panitumumab (vectibix) (3 trials)
panobinostat (farydak) (2 trials)
paricalcitol (zemplar) (1 trial)
pazopanib (votrient) (3 trials)
pembrolizumab (keytruda) (12 trials)
peripheral blood hematopoietic cell (3 trials)
pertuzumab (perjeta) (5 trials)
phentermine (wyamine) (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (4 trials)
polatuzumab vedotin (Polivy) (1 trial)
pralatrexate (folotyn) (1 trial)
prednisolone (hydeltra) (2 trials)
propranolol (inderal) (2 trials)
ramucirumab (cyramza) (7 trials)
ruxolitinib (jakafi) (4 trials)
sacituzumab govitecan (1 trial)
sibutramine (meridia) (1 trial)
sipuleucel-t (provenge) (1 trial)
sirolimus (rapamune) (4 trials)
sodium stibogluconate (1 trial)
tamoxifen (nolvadex) (2 trials)
temsirolimus (torisel) (4 trials)
ticagrelor (brilinta) (1 trial)
trabectedin (yondelis) (2 trials)
trametinib (mekinist) (6 trials)
trastuzumab (herceptin) (19 trials)
trastuzumab emtansine (kadcyla) (1 trial)
tretinoin (Retin-A) (6 trials)
triamcinolone (kenalog) (1 trial)
Tuberculin, Purified Protein Derivative (Tubersol) (3 trials)
tumor-pulsed dendritic cells (1 trial)
tyrosinase/gp100/mart-1 peptides (1 trial)
ustekinumab (stelara) (2 trials)
valaciclovir (Valtrex) (1 trial)
vancomycin (Vancocin) (1 trial)
vemurafenib (zelboraf) (5 trials)
